Evidence map›Paper›PMID 37685376›Full record

ArticleDiagnostics (Basel, Switzerland)2023

Crohn's Disease Prediction Using Sequence Based Machine Learning Analysis of Human Microbiome.

Metehan Unal, Erkan Bostanci, Ceren Ozkul, Koray Acici, Tunc Asuroglu, Mehmet Serdar Guzel

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Observational
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Metehan UnalDepartment of Computer Engineering, Ankara University, 06830 Ankara, Turkey.ORCID 0000-0002-7545-2445
Erkan BostanciDepartment of Computer Engineering, Ankara University, 06830 Ankara, Turkey.ORCID 0000-0001-8547-7569
Ceren OzkulDepartment of Pharmaceutical Microbiology, Faculty of Pharmacy, Hacettepe University, 06230 Ankara, Turkey.ORCID 0000-0002-0921-5863
Koray AciciDepartment of Artificial Intelligence and Data Engineering, Ankara University, 06830 Ankara, Turkey.ORCID 0000-0002-3821-6419
Tunc AsurogluFaculty of Medicine and Health Technology, Tampere University, 33720 Tampere, Finland.ORCID 0000-0003-4153-0764
Mehmet Serdar GuzelDepartment of Computer Engineering, Ankara University, 06830 Ankara, Turkey.ORCID 0000-0002-3408-0083

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human microbiota refers to the trillions of microorganisms that inhabit our bodies and have been discovered to have a substantial impact on human health and disease. By sampling the microbiota, it is possible to generate massive quantities of data for analysis using Machine Learning algorithms. In this study, we employed several modern Machine Learning techniques to predict Inflammatory Bowel Disease using raw sequence data. The dataset was obtained from NCBI preprocessed graph representations and converted into a structured form. Seven well-known Machine Learning frameworks, including Random Forest, Support Vector Machines, Extreme Gradient Boosting, Light Gradient Boosting Machine, Gaussian Naïve Bayes, Logistic Regression, and k-Nearest Neighbor, were used. Grid Search was employed for hyperparameter optimization. The performance of the Machine Learning models was evaluated using various metrics such as accuracy, precision, fscore, kappa, and area under the receiver operating characteristic curve. Additionally, Mc Nemar's test was conducted to assess the statistical significance of the experiment. The data was constructed using k-mer lengths of 3, 4 and 5. The Light Gradient Boosting Machine model overperformed over other models with 67.24%, 74.63% and 76.47% accuracy for k-mer lengths of 3, 4 and 5, respectively. The LightGBM model also demonstrated the best performance in each metric. The study showed promising results predicting disease from raw sequence data. Finally, Mc Nemar's test results found statistically significant differences between different Machine Learning approaches.

Indexed as

bioinformaticsbowel diseaseMachine Learningmicrobiota

Identifiers

PMID37685376
PMCPMC10486516

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.